Title:
ANTI-α-SYNUCLEIN ANTIBODIES AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/221892
Kind Code:
A1
Abstract:
The present invention relates to antibodies specifically binding to α-Synuclein or antigen-binding fragments thereof, a pharmaceutical composition containing the antibodies or the antigen-binding fragments thereof, a nucleic acid molecule encoding the antibodies or the antigen-binding fragments thereof and a host cell comprising same, and related uses. Furthermore, the present invention relates to therapeutic and diagnostic uses of these antibodies or the antigen-binding fragments thereof.
Inventors:
JIN LEI (CN)
LIANG YANGQIU (CN)
REN LIN (CN)
LIU YANG (CN)
LIU YANSHUANG (CN)
LIU SHUANG (CN)
LI TETE (CN)
WANG TAO (CN)
LIANG YANQI (CN)
WANG SIQIN (CN)
LIANG YANGQIU (CN)
REN LIN (CN)
LIU YANG (CN)
LIU YANSHUANG (CN)
LIU SHUANG (CN)
LI TETE (CN)
WANG TAO (CN)
LIANG YANQI (CN)
WANG SIQIN (CN)
Application Number:
PCT/CN2023/093872
Publication Date:
November 23, 2023
Filing Date:
May 12, 2023
Export Citation:
Assignee:
CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/18; A61K39/395; A61P25/16; A61P25/28; C12N1/21; C12N15/13; C12N15/70; G01N33/53
Foreign References:
| CN110172098A | 2019-08-27 | |||
| CN111655727A | 2020-09-11 |
Other References:
DATABASE Protein 24 April 2015 (2015-04-24), ANONYMOUS : "immunoglobulin heavy chain variable region, partial [Homo sapiens] ", XP093110198, retrieved from NCBI Database accession no. CEF90963.1
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF:
Previous Patent: SECURE COMMUNICATION METHOD AND APPARATUS
Next Patent: PROPAGATION DELAY DETERMINATION METHOD AND APPARATUS
Next Patent: PROPAGATION DELAY DETERMINATION METHOD AND APPARATUS